Pillstats
Rx only · Solution/ Drops · Ophthalmic

Brimonidine Tartrate And Timolol Maleate

Brimonidine Tartrate + Timolol Maleate

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)134615
US makers8 labelers
Packages24
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.985$1.97$2.95$3.94Dec 2025Apr 2026Jul 2026
$2.520
Latest avg · Jul 22, 2026
-26%
Since Dec 17, 2025
8
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.5K2.9K4.4K5.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.2K
Rx · 2026 Q1
27K
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown6SUPPLYING
Sandoz Incunknown3SUPPLYING
Upsher-Smith Laboratories, LLCunknown3SUPPLYING
Somerset Therapeutics, LLCunknown3SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
Armas Pharmaceuticals Inc.unknown2SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown2SUPPLYING
NorthStar RxLLCunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.